PCBASKI Stock Latest News
Private CompaniesStroke Awareness Messaging Underscores Basking Biosciences’ Focus on Acute Care Gap2d agoBASKI
Private CompaniesBasking Biosciences Highlights Clinical Progress of RNA Aptamer Stroke Program1w agoBASKI
Private CompaniesInvestigational Stroke Therapy Targets Extended Treatment Window1M agoBASKI
Private CompaniesBasking Biosciences Gains Visibility With Reversible Thrombolytic Stroke Program1M agoBASKI
Private CompaniesFeature Coverage Highlights Basking Biosciences’ Reversible Stroke Therapy Approach1M agoBASKI- Private CompaniesBasking Biosciences Highlights Stroke Program Ahead of Healthcare Conference1M agoBASKI
Private CompaniesStroke Therapy Program Gains Visibility With Progression Into Mid-Stage Trials2M agoBASKI
Private CompaniesBasking Biosciences Reports Positive Phase 1 Data for Stroke Therapy Reversal Agent2M agoBASKIPrivate CompaniesConference Participation Underscores Basking Biosciences’ Focus on Stroke Care2M agoBASKI
Private CompaniesStroke Therapy Limitations Underscore Basking Biosciences’ Market Opportunity2M agoBASKI- Private CompaniesBasking Biosciences – Weekly Recap3M agoBASKI
Private CompaniesPeer-Reviewed Data Strengthen Basking Biosciences’ BB-031 Stroke Program3M agoBASKI- Private CompaniesLeadership Depth Highlighted in Drug Development at Basking Biosciences3M agoBASKI
Private CompaniesBasking Biosciences Highlights Strategic Focus on Acute Ischemic Stroke3M agoBASKIPrivate CompaniesScientific Engagement Underscores Basking Biosciences’ Focus on Thrombosis and Stroke3M agoBASKI
Private CompaniesExperienced Leadership and Stroke Program Spotlight at Basking Biosciences3M agoBASKI